Point72 Hong Kong Ltd Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Point72 Hong Kong Ltd boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 114.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 19,230 shares of the medical equipment provider's stock after purchasing an additional 10,280 shares during the quarter. Point72 Hong Kong Ltd's holdings in Intuitive Surgical were worth $10,037,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent research reports. Piper Sandler reduced their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Leerink Partners upped their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Royal Bank of Canada reduced their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Raymond James lifted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $598.95.

Insider Buying and Selling

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $3.32 during trading hours on Friday, hitting $563.60. The stock had a trading volume of 1,422,176 shares, compared to its average volume of 1,644,552. Intuitive Surgical, Inc. has a 12-month low of $395.60 and a 12-month high of $616.00. The firm has a market cap of $202.00 billion, a P/E ratio of 87.93, a P/E/G ratio of 5.85 and a beta of 1.70. The company's fifty day simple moving average is $505.22 and its 200 day simple moving average is $536.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the business posted $1.50 EPS. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.